Diagnostics News and Research

RSS

Mount Sinai Brooklyn launches FastER Track program to expedite care for patients

Mount Sinai Brooklyn has launched a FastER Track program in its emergency department (ED) that will expedite care for patients, especially those with non-urgent medical needs. T

31 Oct 2019

Scientists receive $1.6 million grant to study impact of phthalate exposure on male fertility

A cross-disciplinary team of scientists, led by University of Massachusetts Amherst environmental epigeneticist Richard Pilsner, will use a three-year, $1.6 million grant from the National Institute of Environmental Health Sciences to expand research into the impact of phthalate exposure on male fertility.

30 Oct 2019

Beckman Coulter receives BARDA funding to develop novel sepsis detection algorithm

Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the DRIVe (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority, under the Office of the Assistant Secretary for Preparedness and Response, within the United States Department of Health and Human Services.

From Beckman Coulter Diagnostics 30 Oct 2019

Scientists modify a toxic protein to create a biosensor

Researchers have shown that the pore-forming toxin (PFT), aerolysin, could be used as a biosensor in the sequencing of DNA and proteins.

30 Oct 2019

New BD MAX Check-Points CPO assay receives FDA 510(k) clearance

BD (Becton, Dickinson and Company), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening test for antibiotic-resistant carbapenemase-producing organisms on the fully-automated BD MAX System.

From BD (Becton, Dickinson and Company) 30 Oct 2019

Novel, cost-effective method successfully identifies aggressive tumors

Researchers have developed a novel, cost-effective genomic method that can identify highly heterogenous tumors that are typically aggressive in nature.

30 Oct 2019

Rutgers selected to speed up development of biomedical health technologies

Rutgers, The State University of New Jersey was selected as one of five new hubs under the National Institutes of Health's Research Evaluation and Commercialization Hubs program to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics, and tools to improve patient care, enhance health, and train the next generation of innovators.

29 Oct 2019

First effective noninvasive method for diagnosing early-stage liver diseases

A safer and more sensitive contrast dye for MRI tests developed by a team led by Georgia State University researchers may provide the first effective, noninvasive method for detecting and diagnosing early-stage liver diseases, including liver fibrosis.

29 Oct 2019

Researchers develop new test to detect nutrient deficiencies in harsh environments

Mothers and children in low resource communities may appear well fed but often suffer from micronutrient deficiencies.

29 Oct 2019

NUS researchers use glowing nanoparticles to control biological processes

The biological technique of 'optogenetics' uses light to control cells within living tissues that have been genetically modified to be light-sensitive.

29 Oct 2019

Flinders University study provides new insights into how the colon functions

New insights into how the colon functions and actually expels its contents have been revealed for the first time following decades of study by Flinders University researchers.

29 Oct 2019

New research could help better understand progress of breast cancer

New research at Case Western Reserve University could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

29 Oct 2019

Sense Biodetection raises £12.3m to develop instrument-free, point-of-care molecular diagnostic tests

Sense Biodetection Limited has today announced that it has raised £12.3m to develop its portfolio of instrument-free, point-of-care molecular diagnostic tests, a pioneering new class of diagnostic product.

29 Oct 2019

Skin cancer diagnosis using AI technology could be as accurate as clinical specialist

New clinical data published in Journal of American Medical Association demonstrates first-in-class AI algorithm is able to diagnose skin cancer with a high-level of accuracy comparable to a clinical specialist.

29 Oct 2019

Faster Identification of Bacterial Infections Using Raman Spectroscopy Could Save Lives

Utilising a Renishaw Raman spectroscopy system, a team of researchers from the Czech Academy of Sciences have been testing a novel way to identify Staphylococcal bacteria, paving the way for faster diagnosis and treatment of infectious diseases.

29 Oct 2019

New research may contribute to diagnostics of cancer

A team of researchers from the Institute of Materials Science at Kaunas University of Technology, Lithuania together with colleagues from Japan and Latvia came up with a method that forces over 300 million metal nanoparticles to self-assemble into regular structures, which enhance their interaction with light by orders of magnitude.

28 Oct 2019